In the context of clinical observations in HCC patients, several studies have revealed that an imbalance of MMP2 and TIMP2 expression is associated with poorer prognosis of HCC (Giannelli et al., 2002; Daniele et al., 2014). Here, TIMP2 is linked to hepatocellular carcinoma.